Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells

Biomedicine and Pharmacotherapy

Volumn 59, Issue 7, 2005, Pages 359-364

  Gagliano, Nicoletta ^a   Moscheni, Claudia ^a   Torri, Carlo ^a   Magnani, Ivana ^a   Bertelli, Alberto A ^a   Gioia, Magda ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Glioblastoma; MMP 2; Resveratrol; SPARC

Indexed keywords

GELATINASE A; MESSENGER RNA; OSTEONECTIN; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TUMOR CELL CULTURE; WESTERN BLOTTING; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 2; OSTEONECTIN; RNA, MESSENGER; STILBENES;

EID: 24044485878     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.06.001     Document Type: Article

References (45)

1. P. Kleihues, F. Soylemezoglu, B. Schauble, B.W. Scheithauer, and P.C. Burger Histopathology, classification, and grading of gliomas Glia 15 1995 211 221
2. A. Sehgal Molecular changes during the genesis of human gliomas Semin. Surg. Oncol. 14 1998 3 12
3. S.K. Chintala, J.C. Tonn, and J.S. Rao Matrix metalloproteinases and their biological function in human gliomas Int. J. Dev. Neurosci. 17 1999 495 502
4. F.J. Woessner Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J. 5 1991 2145 2154
5. H.K. Rooprai, and D. McCormick Proteases and their inhibitors in human brain tumours: a review Anticancer Res. 17 1997 4151 4162
6. W.G. Stetler-Stevenson, and A.E. Yu Proteases in invasion: matrix metalloproteinases Cancer Biol. 11 2001 143 152
7. G.H. Vince, S. Wagner, T. Pietsch, R. Klein, R.H. Goldbrunner, and K. Rosen Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas Int. J. Dev. Neurosci. 17 1999 437 445
8. P.A. Forsyth, H. Wong, T.D. Laing, N.B. Rewcastle, D.G. Morris, and H. Muzik Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br. J. Cancer 79 1999 1828 1835
9. M. Wang, T. Wang, S. Liu, D. Yoshida, and A. Teramoto The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades Brain Tumor Pathol. 20 2003 65 72
10. P. Bornstein, and E.H. Sage Matricellular proteins: extracellular modulators of cell function Curr. Opin. Cell Biol. 14 2002 608 616
11. A.D. Bradshaw, and E.H. Sage SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury J. Clin. Invest. 107 2001 1049 1054
12. R.A. Brekken, and E.H. Sage SPARC, a matricellular protein: at the crossroads of cell-matrix communication Matrix Biol. 19 2000 569 580
13. P.M. Tremble, T.F. Lane, E.H. Sage, and Z. Werb SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway J. Cell Biol. 121 1993 1433 1444
14. W.A. Golembieski, S. Ge, K. Nelson, T. Mikkelsen, and S.A. Rempel Increased SPARC expression promotes U87 glioblastoma vasion in vitro Int. J. Dev. Neurosci. 17 1999 463 472
15. C. Schultz, N. Lemke, S. Ge, W.A. Golembieski, and S.A. Rempel Secreted protein acidic and rich in cysteine promotes gliomi invasion and delays tumor growth in vivo Cancer Res. 62 2002 6270 6277
16. P. Vajkoczy, M.D. Menger, R. Goldbrunner, S. Ge, T.A.T. Fong, and B. Vollmar Targeting angiogenesis inhibits tumor infiltration and expresssion of the proinvasive protein SPARC Int. J. Cancer 87 2000 261 268
17. C. Daumas-Duport, B. Scheithauer, J. O'Fallon, and P. Kelly Grading of astrocytomas. A simple and reproducible method Cancer 62 1988 2152 2165
18. W.R. Shapiro Current therapy for brain tumors Arch. Neurol. 56 1999 429 432
19. T. Dorai, and B.B. Aggarwal Role of chemopreventive agents in cancer therapy Cancer Lett. 215 2004 129 140
20. L. Freemont Biological effects of Resveratrol Life Sci. 66 2000 663 673
21. G.J. Soleas, E.P. Diemandis, and D.M. Goldberg Resveratrol. A molecule whose time has come? And gone? Clin. Biochem. 30 1997 91 113
22. M. Jang, L. Cai, G.O. Udeani, K.W. Slowing, C.F. Thomas, and C.W.W. Beecher Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
23. J.F. Savouret, and M. Quesne Resveratrol and cancer: a review Biomed. Pharmacother. 56 2002 84 87
24. M. Demeule, M. Brossard, M. Page, D. Gingras, and R. Beliveau Matrix metalloproteinase inhibition by green tea catechins Biochim. Biophys. Acta 1478 2000 51 60
25. S.H. Tseng, S.M. Lin, J.C. Chen, Y.H. Su, H.Y. Huang, and C.K. Chen Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats Clin. Cancer Res. 10 2004 2190 2202
26. I. Magnani, S. Guerneri, B. Pollo, N. Cirenei, B.M. Colombo, and G. Broggi Increasing complexity of the karyotype in 50 human gliomas Cancer Genet. Cytogenet. 75 1994 77 89
27. D.E. Kleiner, and W.G. Stetler-Stevenson Quantitative zymography: detection of picogram quantities of gelatinases Anal. Biochem. 218 1994 325 329
28. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
29. W.M. Burnette "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A Anal. Biochem. 112 1981 195 203
30. Q. Wang, J. Xu, G.E. Rottinghaus, A. Simonyi, D. Lubahn, and G.Y. Sun Resveratrol protects against global cerebral ischemic injury in gerbils Brain Res. 958 2002 439 447
31. N. Ahmad, V.M. Adhami, F. Afaq, D.K. Feyes, and H. Mukhtar Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells Clin. Cancer Res. 7 2001 1466 1473
32. M.V. Clement, J.L. Hirpara, S.H. Chawdhury, and S. Pervaiz Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996 1002
33. C. Huang, W.Y. Ma, A. Goranson, and Z. Dong Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis 20 1999 237 242
34. J.W. Park, Y.J. Choi, M.A. Jang, Y.S. Lee, D.Y. Jun, and S.I. Suh Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells Cancer Lett. 163 2001 43 49
35. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: multifunctional contributors to tumor progression Mol. Med. Today 6 2000 149 156
36. J.R. Rao Molecular mechanisms of glioma invasiveness: the role of proteases Nature Rew. Cancer 3 2003 489 501
37. S.A. Rempel, W.A. Golembieski, J.L. Fisher, M. Maille, and A. Nkeff SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins J. Neurooncol. 53 2001 149 160
38. A.A. Bertelli, L. Giovannini, R. Stradi, S. Urien, J.P. Tillement, and A. Bertelli Kinetics of trans- and cis-resveratrol (3,4′,5- trihydroxystilbene) after red wine oral administration in rats Int. J. Clin. Pharmacol. Res. 16 1996 77 81
39. G. Nicolini, R. Rigolio, A. Scuteri, M. Miloso, D. Saccomanno, and G. Cavaletti Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells Neurochem. Int. 42 2003 419 429
40. X. Gao, Y.X. Xu, N. Janakiraman, R.A. Chapman, and S.C. Gautam Immunomodulatory activity of resveratrol: suppression of lynphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production Biochem. Pharmacol. 62 2001 1299 1308
41. S. Godichaud, S. Krisa, B. Couronne, L. Dubuisson, J.M. Merillon, and A. Desmouliere Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol Hepatology 31 2000 922 931
42. Y.P. Han, T.L. Tuan, H. Wu, M. Hughes, and W.L. Garner TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP J. Cell Sci. 114 2001 131 139
43. S. Philip, A. Bulbule, and G.C. Kundu Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells J. Biol. Chem. 276 2001 44926 44935
44. J.K. Kundu, and Y.J. Surh Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets Mutat. Res. 555 2004 65 80
45. Q. Shi, S. Bao, J.A. Maxwell, E.D. Reese, H.S. Friedman, and D.D. Bigner Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation J. Biol. Chem. 279 2004 52200 52209